On November 7, 2024, Alisha Charlton, Chief Financial Officer of Pro-Dex Inc (PDEX, Financial), sold 1,000 shares of the company at a price of $40.02 per share. The transaction was documented in an SEC Filing. Following this sale, the insider now owns 15,339 shares of Pro-Dex Inc.
Pro-Dex Inc specializes in the design, development, and manufacturing of rotary drive systems, primarily for the medical and dental industries. The company's products include precision medical devices and dental instruments that are integral to various surgical and dental procedures.
Over the past year, the insider transaction history for Pro-Dex Inc shows a total of 2 insider sells and 0 insider buys. This recent sale by Alisha Charlton aligns with the ongoing trend of insider sales within the company.
Shares of Pro-Dex Inc were trading at $40.02 on the day of the sale, giving the company a market cap of $139.112 million. The price-earnings ratio of the stock stands at 27.90, which is below the industry median of 29.77 but above the company's historical median.
According to the GF Value, Pro-Dex Inc is significantly overvalued with a price-to-GF-Value ratio of 1.71. The GF Value of $23.46 suggests a potential overvaluation in the stock's current trading price.
The GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor and future business performance estimates from Morningstar analysts.
This insider sale might draw the attention of current and potential investors, especially considering the company's valuation and the recent trading price relative to its GF Value.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
